Alaunos Therapeutics Stock Forecast

Stock Price Forecast

There have not been any analyst price target forecasts for Alaunos Therapeutics in the last 12 months.

Price Target: n/a

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for Alaunos Therapeutics.

Recommendation Trends

Rating	Mar '23	Apr '23	May '23	Jun '23	Jul '23
Strong Buy	0	0	1	1	1
Buy	3	3	3	3	3
Hold	0	0	0	0	0
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	3	3	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Swayampakula Ramakanth HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Aug 16, 2023
Yale Jen Laidlaw & Co.	Laidlaw & Co.	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Aug 15, 2023
Swayampakula Ramakanth HC Wainwright & Co.	HC Wainwright & Co.	Hold → Strong Buy Upgrades $225	Hold → Strong Buy	Upgrades	$225	+7,501.35%	May 15, 2023
Yanan Zhu Wells Fargo	Wells Fargo	Buy Initiates $450	Buy	Initiates	$450	+15,102.70%	Mar 27, 2023
Nick Abbott Wells Fargo	Wells Fargo	Buy Initiates $450	Buy	Initiates	$450	+15,102.70%	Oct 4, 2022

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 5.00K

Revenue Next Year

n/a

EPS This Year

-0.14

from -2.20

EPS Next Year

n/a

from -0.14

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	398.00K	2.92M	5.00K	10.00K	5.00K	-
Revenue Growth	-	634.17%	-99.83%	100.00%	-50.00%	-
EPS	-55.10	-26.10	-21.97	-2.92	-2.20	-0.14
EPS Growth	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Revenue Growth	2026
High	-
Avg	-
Low	-

EPS Forecast

EPS	2026
High	-0.15
Avg	-0.14
Low	-0.14

EPS Growth

EPS Growth	2026
High	-
Avg	-
Low	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.